Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-24

FDA Approved: XDEMVY — Original Application (Tarsus Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved XDEMVY (lotilaner ophthalmic solution) from Tarsus Pharmaceuticals for the treatment of Demodex blepharitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XDEMVY (lotilaner)

Snippet

ORIG AP for XDEMVY (LOTILANER OPHTHALMIC SOLUTION)